|
HSP90B3P expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.68229999999836E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.559500E-04 |
| Normal-vs-Stage2 |
1.301170E-01 |
| Normal-vs-Stage3 |
6.238300E-04 |
| Normal-vs-Stage4 |
4.50549999997385E-06 |
| Stage1-vs-Stage2 |
1.026210E-01 |
| Stage1-vs-Stage3 |
4.868800E-01 |
| Stage1-vs-Stage4 |
5.681700E-03 |
| Stage2-vs-Stage3 |
5.695900E-02 |
| Stage2-vs-Stage4 |
5.431100E-04 |
| Stage3-vs-Stage4 |
1.696560E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.171300E-04 |
| Normal-vs-AfricanAmerican |
3.8254999999987E-05 |
| Normal-vs-Asian |
5.950700E-04 |
| Caucasian-vs-AfricanAmerican |
6.145800E-02 |
| Caucasian-vs-Asian |
6.895000E-01 |
| AfricanAmerican-vs-Asian |
1.692190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.765100E-04 |
| Normal-vs-Female |
2.848700E-04 |
| Male-vs-Female |
5.979200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.217300E-03 |
| Normal-vs-Age(41-60Yrs) |
6.790400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.775460E-03 |
| Normal-vs-Age(81-100Yrs) |
1.738430E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.033800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.090200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.545600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.533600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.656000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.526400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.362040E-03 |
| Classical-VS-Follicular |
1.039830E-02 |
| Classical-VS-Other |
8.848800E-01 |
| Classical-VS-Normal |
7.73420000000913E-05 |
| Tall-VS-Follicular |
7.20219999972294E-07 |
| Tall-VS-Other |
5.136400E-01 |
| Tall-VS-Normal |
7.6327999998238E-07 |
| Follicular-VS-Other |
2.968000E-01 |
| Follicular-VS-Normal |
9.734200E-02 |
| Other-VS-Normal |
1.232000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.237770E-02 |
| Normal-vs-N1 |
1.66229999987166E-07 |
| N0-vs-N1 |
1.55710000004916E-07 |
|
|
